acrolein has been researched along with naringin in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Arumugam, S; Girish Subbiah, K; Kemparaju, K; Thirunavukkarasu, C | 1 |
| Kim, JK; Kim, SH; Ku, HJ; Lee, JH; Lim, YJ; Park, JH; Park, JW | 1 |
2 other study(ies) available for acrolein and naringin
| Article | Year |
|---|---|
Neutrophil extracellular traps in acrolein promoted hepatic ischemia reperfusion injury: Therapeutic potential of NOX2 and p38MAPK inhibitors.
Topics: Acetophenones; Acrolein; Animals; Antioxidants; Apoptosis; Cell Death; Cell Nucleus; Chemotaxis; DNA Damage; Enzyme Inhibitors; Extracellular Traps; Flavanones; Hep G2 Cells; Histones; Humans; Inflammation Mediators; Liver; Male; MAP Kinase Signaling System; Mitochondria; NADPH Oxidase 2; Neutrophils; p38 Mitogen-Activated Protein Kinases; Peroxidase; Rats, Wistar; Reperfusion Injury; Respiratory Burst; Tumor Necrosis Factor-alpha | 2018 |
Naringin protects acrolein-induced pulmonary injuries through modulating apoptotic signaling and inflammation signaling pathways in mice.
Topics: Acrolein; Animals; Apoptosis; Biomarkers; Cytokines; Flavanones; Lung Injury; Male; Mice, Inbred C57BL; NF-kappa B; Pneumonia; Reactive Oxygen Species | 2018 |